News from ASH 2020: 'Practice-changing' results with ruxolitinib in chronic GVHD and no benefit seen with tranexamic acid in patients with blood cancers and severe thrombocytopenia
News from ASH 2020:
Email Blood & Cancer at podcasts@mdedge.com
Create your
podcast in
minutes
It is Free